SCHEMBL31079008

SCHEMBL31079008

Cc1cc(-c2cc(-c3ccc4c(c3)CCNC4=O)c(N)nc2F)cc2c1CCN(CCCC(F)F)C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 7/20 0.35
MAPK1 P28482 1/20 0.35
PARP10 Q53GL7 5/20 0.35
PARP11 Q9NR21 5/20 0.35
MAPK9 P45984 1/20 0.34
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCND3 P30281 1/20 0.34
CDK6 Q00534 1/20 0.34
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GRM5 P41594 1/20 0.33
MAP4K1 Q92918 1/20 0.32
CD274 Q9NZQ7 1/20 0.32
DAPK3 O43293 1/20 0.32
NTRK1 P04629 1/20 0.32
PIM1 P11309 1/20 0.32
FLT3 P36888 1/20 0.32
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31079175 0.88 MAPKAPK2 (0.38) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL29964253 0.86 PARP10 (0.40) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL29964433 0.82 MAPK1 (0.39) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL31079267 0.79 CDK4 (0.35) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL29964535 0.78 PARP10 (0.42) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL29964929 0.78 CDK4 (0.43) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL31079095 0.77 MAPK1 (0.40) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL29964207 0.77 MAPKAPK2 (0.40) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL31079103 0.76 PARP10 (0.55) MAPKAPK2MAPK1PARP10PARP11MAPK9
SCHEMBL31079110 0.75 MAPK1 (0.40) MAPKAPK2MAPK1PARP10PARP11MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 MAPKAPK2 79/4885MAPK1 141/4885PARP10 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.